Cardinal Health

Cardinal Health, a Drugs and Druggists' Sundries Merchant Wholesalers headquartered in the US, has committed to significant greenhouse gas (GHG) emission reductions. For fiscal year 2025, the company reported a total of approximately 20.14 billion kg CO2e. This figure comprises Scope 1 emissions of roughly 154.4 million kg CO2e, Scope 2 emissions of about 197.8 million kg CO2e, and Scope 3 emissions totalling approximately 19.79 billion kg CO2e. Of the Scope 3 emissions, purchased goods and services represented the largest contributor at about 18.34 billion kg CO2e, followed by upstream transportation and distribution at approximately 788.2 million kg CO2e.

In fiscal year 2024, Cardinal Health's total emissions were approximately 22.27 billion kg CO2e, with Scope 1 at around 160.2 million kg CO2e, Scope 2 at roughly 204.7 million kg CO2e, and Scope 3 at approximately 21.91 billion kg CO2e.

Cardinal Health has set an ambitious target to reduce absolute Scope 1 and 2 GHG emissions by 50% by fiscal year 2030, using a fiscal year 2019 base year. This commitment is recognised by the Science Based Targets initiative (SBTi) as being consistent with reductions required to keep warming to 1.5°C. The company also aims for 75% of its suppliers, by spend, to have science-based targets by fiscal year 2028, specifically covering purchased goods and services and upstream transportation and distribution.

The company's reporting indicates a decreasing trend in Scope 1 and 2 emissions, from approximately 423.5 million kg CO2e in fiscal year 2019 to around 352.2 million kg CO2e in fiscal year 2025. Cardinal Health has been transparent about its emissions data, disclosing Scope 1, 2, and 3 emissions in its reports.